This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International

Book Now! Early Registration Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

Weitao Jia, Ph.D.
Director, CMC Analytical Development Technical Operations at Ultragenyx


Dr. Weitao Jia is the Director in CMC Analytical Development at Ultragenyx, California. He is currently leading a late-stage BLA project and working on a few early-stage development projects including mRNA-based therapeutics. Dr. Jia was previously working at Roche/Genentech for 9 years and was the CMC characterization/analytical lead as well as the global analytical technology transfer lead of Susvimo® which received FDA’s approval in October 2021. He earned his Ph.D. in Analytical Chemistry and gained extensive CMC development experiences via working on a few BLA projects with successful commercial launches and leading characterization/analytical work for Phase I/III INDs/CTAs.

Speakers at this event